Tysabri every eight weeks may cut PML risk
Tysabri every eight weeks may cut PML risk
Preliminary findings from an ongoing study of multiple sclerosis patients suggest the dosing interval for Tysabri can be as much as doubled from the label-recommended standard without sacrificing efficacy, and with potentially less risk of progressive multifocal leukoencephalopathy (PML) -- even among patients with more than average PML risk, researchers claim... Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2305 Views
-
Last post by NHE
-
- 6 Replies
- 6550 Views
-
Last post by ElliotB
-
- 0 Replies
- 1332 Views
-
Last post by NHE
-
- 0 Replies
- 3429 Views
-
Last post by NHE
-
- 1 Replies
- 1019 Views
-
Last post by NHE
-
- 1 Replies
- 1514 Views
-
Last post by NHE
-
- 11 Replies
- 3352 Views
-
Last post by NHE
-
- 0 Replies
- 3157 Views
-
Last post by NHE
-
- 0 Replies
- 1362 Views
-
Last post by NHE